Differences Between Third and Fourth Generation Cephalosporins
Fourth-generation cephalosporins have enhanced activity against both gram-positive and gram-negative bacteria, including many resistant strains, making them valuable options for treating serious infections when other antibiotics may be ineffective. 1
Structural and Pharmacological Differences
Chemical Structure: Fourth-generation cephalosporins (like cefepime) have a quaternary nitrogen that is positively charged at the 3-position, providing zwitterionic properties, and a 2-aminothiazolyl-acetamido group with an alpha-oxyimino substitution at the 7-position 2
Beta-lactamase Stability: Fourth-generation cephalosporins have:
Cell Penetration: Fourth-generation cephalosporins demonstrate rapid penetration into the periplasmic space of bacteria, contributing to their high intrinsic potency 3
Antimicrobial Spectrum Differences
Third-Generation Cephalosporins (e.g., ceftriaxone, cefotaxime, ceftazidime)
- Good gram-negative coverage
- Variable gram-positive activity
- Some have specific advantages:
Fourth-Generation Cephalosporins (e.g., cefepime)
- Broader spectrum than third-generation agents 4
- Improved activity against gram-positive organisms while maintaining excellent gram-negative coverage 2, 4
- Active against many multi-resistant gram-negative bacteria, including Enterobacter and Klebsiella species 3
- Effective against many strains resistant to third-generation cephalosporins 4
Specific Pathogen Coverage
Enhanced Coverage by Fourth-Generation Agents
Enterobacteriaceae: Fourth-generation agents maintain activity against many ESBL-producing strains and are more stable against chromosomally-mediated AmpC beta-lactamases 3, 4
Pseudomonas aeruginosa: Fourth-generation cephalosporins like cefepime have comparable or better activity against P. aeruginosa than third-generation agents like ceftazidime 5
Gram-positive organisms: Fourth-generation cephalosporins have improved activity against Staphylococcus aureus (methicillin-susceptible strains) and Streptococcus species compared to third-generation agents 3, 4
Clinical Applications
Resistant Infections: Fourth-generation cephalosporins are particularly valuable for treating infections caused by organisms resistant to third-generation cephalosporins 4
Nosocomial Infections: Fourth-generation agents are often preferred for serious hospital-acquired infections due to their activity against resistant pathogens 3
Empiric Therapy: Fourth-generation cephalosporins can be used as monotherapy in situations where third-generation agents might require combination therapy 5
Dosing Advantages
- Dosing Frequency: Fourth-generation cephalosporins like cefepime can often be administered less frequently (e.g., twice daily) compared to some third-generation agents that require three-times-daily dosing 4
Important Limitations for Both Generations
- Neither third nor fourth-generation cephalosporins typically cover:
Clinical Considerations
Despite theoretical advantages, clinical trials have not consistently demonstrated superior efficacy of fourth-generation over third-generation cephalosporins in head-to-head comparisons 4
Fourth-generation cephalosporins should be used judiciously to prevent development of resistance 1
Local resistance patterns should guide selection between third and fourth-generation agents 1
Summary
Fourth-generation cephalosporins represent an advancement over third-generation agents primarily through their enhanced stability against beta-lactamases, broader spectrum of activity that better covers both gram-positive and gram-negative pathogens, and activity against many strains resistant to third-generation agents. They are particularly valuable for treating serious infections caused by resistant organisms, though judicious use is essential to preserve their effectiveness.